New Edge Advisors, LLC Charles River Laboratories International, Inc. Transaction History
New Edge Advisors, LLC
- $15 Billion
- Q3 2024
A detailed history of New Edge Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 646 shares of CRL stock, worth $126,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
646
Previous 2,314
72.08%
Holding current value
$126,467
Previous $478,000
73.43%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$996 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$732 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$417 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$380 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.96B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...